Esperion Therapeutics | Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amarin USD 628.33M 21.52M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cipla INR 249.18B 16.3B 2025-09
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Geron USD 520.27M 2.07M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 13.02M 2.53M 2025-09
Moderna USD 6.54B 54M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12


Esperion Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.